Concepedia

Publication | Open Access

SLIT3 promotes myogenic differentiation as a novel therapeutic factor against muscle loss

27

Citations

31

References

2021

Year

Abstract

SLIT3 plays a sarcoprotective role by activating β-catenin signalling. SLIT3 LRRD2 can potentially be used as a therapeutic agent against muscle loss.

References

YearCitations

2018

13.1K

2001

598

2003

515

2004

384

2018

349

2013

289

2013

275

2018

164

2007

161

2011

160

Page 1